Newsfeed : Open Letter Urges FDA to Not Delay MSM Access to PrEP

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » October 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


October 21, 2011

Open Letter Urges FDA to Not Delay MSM Access to PrEP

Several nonprofit organizations and coalitions have signed an open letter to the U.S. Food and Drug Administration (FDA) and Gilead Sciences urging them not to delay approval of Truvada, which is made by Gilead, for pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) and transgender people, according to a statement by the AIDS Vaccine Advocacy Coalition (AVAC). Gilead is seeking FDA approval of Truvada as an HIV prevention in both MSM and heterosexual people; it plans to combine the request for each groups into a single filing. The signers are concerned that reviewing the data for heterosexual people will unnecessarily delay access to PrEP by MSM. The signers include AIDS Action Committee of Massachusetts, AIDS Foundation of Chicago, AIDS Research Consortium of Atlanta, AIDS United, AVAC, Black AIDS Institute, Fenway Health, GMHC, Harlem United, International Rectal Microbicides Advocates, National Minority AIDS Council, Project Inform and San Francisco AIDS Foundation.

To read the open letter, click here.


Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (7 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.